AGS-M – nouveau membre

 AGS-M develops cutting-edge processes for the mass production of microalgae extracellular vesicles (MEV) and produce GMP-grade batches of MEV as drug delivery systems (DDS) for phase I and phase II clinical trials. En savoir plus